Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Loging

Orthopaedic Surgery Clinton, SC Medical Doctor

NPI 1669490405 CMS profile 120623

22971 Highway 76 E, Clinton, SC 29325

Open in the dashboard

General payments

$117,579

333 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, James Loging of Clinton, SC is reported in the CMS Open Payments database as having received $117,579 across 333 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,007 32
2024 General $4,222 30
2023 General $13,223 41
2022 General $48,280 77
2021 General $31,180 74
2020 General $7,454 28
2019 General $12,214 51

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Loging
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to James Loging were reported at $1,007. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year James Loging Orthopaedic Surgery median Middle half National median
2019 $12,214 $644 $140–$2,844 $163
2020 $7,454 $312 $75–$1,860 $114
2021 $31,180 $520 $117–$2,495 $132
2022 $48,280 $598 $128–$2,731 $149
2023 $13,223 $461 $128–$2,264 $160
2024 $4,222 $497 $134–$2,475 $164
2025 $1,007 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $62,968 140 payments
  2. SI-BONE, Inc. $47,648 41 payments
  3. Medtronic USA, Inc. $2,136 20 payments
  4. RTI Surgical, Inc. $1,352 5 payments
  5. Abbott Laboratories $758 14 payments
  6. Medtronic, Inc. $579 19 payments
  7. Amgen Inc. $268 16 payments
  8. Stryker Corporation $234 5 payments
  9. MML US, Inc. $141 7 payments
  10. Electronic Waveform Lab, Inc. $132 1 payment
  11. Other $1,364 65 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $54,606 26 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $47,156 39 payments
  3. Food and Beverage $9,033 242 payments
  4. Travel and Lodging $6,784 26 payments
Products named General payments · program years 2019–2025
  1. IFUSE IMPLANT $37,631 22 payments
  2. JOURNEY II BCS $25,200 26 payments
  3. JOURNEY II CR $23,388 25 payments
  4. JOURNEY II Recon Knees $19,430 24 payments
  5. JOURNEY II UK $16,978 19 payments
  6. JOURNEY II XR $15,390 19 payments
  7. REAL INTELLIGENCE $10,623 22 payments
  8. LEGION TKS $10,361 14 payments
  9. IFUSE IMPLANT SYSTEM $9,408 11 payments
  10. JOURNEY II Recon Knees $9,298 9 payments
  11. Other $69,014 335 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

1,721

Median for Orthopedic Surgery: 203

Drug cost

$25,685

Median for Orthopedic Surgery: $1,433

Branded share of claims

30.1%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 21 $12,129
Nabumetone Generic 349 $4,137
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 194 $2,584
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 180 $1,811
Gabapentin Generic 293 $1,095
Clindamycin Hcl Generic 157 $763
Celecoxib Generic 15 $651
Ondansetron Hcl Generic 126 $559
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 123 $552
Prednisone Generic 37 $475

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 107 billing codes

Paid by Medicare

$729,870

Of which drugs: $115,957

Medicare patients

1,225

Average age 75

Services billed

86,378

776 women, 449 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 28%
Diabetes 26%
Depression 24%
Chronic kidney disease 21%
Atrial fibrillation 18%
Osteoporosis 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg J7318 Office 109 9,300 $46,142
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg J7325 Office 86 6,192 $43,571
Injection, denosumab, 1 mg J0897 Office 11 722 $12,966
Injection, methylprednisolone acetate, 1 mg J1010 Office 364 63,008 $5,614
Injection, methylprednisolone acetate, 40 mg J1030 Office 175 520 $2,157
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml Q9966 Office 26 38 $11

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
EVENITY
  • Amgen Inc. $37
$37 — —
BOTOX
  • AbbVie, Inc. $25
$25 — —
Prolia
  • Amgen Inc. $17
$17 — 722
Exparel
  • Pacira Pharmaceuticals Incorporated $14
$14 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

333 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record